Why it matters: The story further underscores reporting that health and scientific agencies are undergoing a deep politicization as the Trump administration races to develop a coronavirus vaccine, as Axios’ Caitlin Owens has reported. Peter Lurie, a former associate commissioner of the FDA, told the Times that the Azar memo amounted to a “power grab.”
What they’re saying: Brian Harrison, Azar’s chief of staff, said the changes were simply a “housekeeping matter.”
- “This good governance, housekeeping action, which should have no operational impact because all rules already required departmental clearance, will prevent potential future abuse of authority and is clearly consistent with congressional intent,” Harrison said.
- “This has nothing to do with guidances or any vaccine, drug, or therapeutic approval. Assertions that this was aimed at any specific division or leader are dishonest or uninformed.”
Other outside experts believe that the memo could further hinder scientific voices. The CDC this week reversed course on a controversial policy concerning coronavirus testing for asymptomatic people, which was reportedly posted to the agency’s website over the objections of scientists.
Go deeper: Trump contradicts CDC chief on when vaccine will be widely available
Editor’s note: This story has been updated to remove references to vaccines, which do not go through the rule-making process.
Send your news and stories to us email@example.com or firstname.lastname@example.org and WhatsApp: +447747873668.
Before you go...
Democratic norms are being stress-tested all over the world, and the past few years have thrown up all kinds of questions we didn't know needed clarifying – how long is too long for a parliamentary prorogation? How far should politicians be allowed to intervene in court cases? To monitor these issues as closely as we have in the past we need your support, so please consider donating to The Climax News Room.